240 related articles for article (PubMed ID: 20088012)
1. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
[TBL] [Abstract][Full Text] [Related]
3. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.
Biondi-Zoccai G; Sheiban I; Moretti C; Palmerini T; Marzocchi A; Capodanno D; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Pede Fd; Ramondo A; Medda M; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; de Servi S
Clin Res Cardiol; 2011 May; 100(5):403-11. PubMed ID: 21128078
[TBL] [Abstract][Full Text] [Related]
4. Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry.
Sheiban I; Sillano D; Biondi-Zoccai G; Moretti C; Garrone P; Lombardi P; Sciuto F; Omedè P; Iacovino C; Spina CL; Trevi GP
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):461-8. PubMed ID: 19395977
[TBL] [Abstract][Full Text] [Related]
5. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
7. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
[TBL] [Abstract][Full Text] [Related]
9. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
Kunadian V; Pugh A; Zaman AG; Qiu W
Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
[TBL] [Abstract][Full Text] [Related]
11. Time for left main stenting in patients with LV dysfunction? Proceed with caution!
Uretsky BF
Catheter Cardiovasc Interv; 2010 Mar; 75(4):594-5. PubMed ID: 20333658
[No Abstract] [Full Text] [Related]
12. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
[TBL] [Abstract][Full Text] [Related]
13. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
14. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
[TBL] [Abstract][Full Text] [Related]
16. Impact of diabetes mellitus on the treatment effect of percutaneous or surgical revascularization for patients with unprotected left main coronary artery disease: a subgroup analysis of the MAIN-COMPARE study.
Kim WJ; Park DW; Yun SC; Lee JY; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2009 Oct; 2(10):956-63. PubMed ID: 19850255
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction.
Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
Am J Cardiol; 2013 Sep; 112(5):623-9. PubMed ID: 23711811
[TBL] [Abstract][Full Text] [Related]
19. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).
Mieres J; Fernandez-Pereira C; Risau G; Solorzano L; Pauletto R; Rodriguez-Granillo AM; Rubilar B; Stella P; Rodriguez AE
Cardiovasc Revasc Med; 2012; 13(5):265-71. PubMed ID: 22796496
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in baseline characteristics and peri-procedural complications of percutaneous drug-eluting stent implantation for unprotected left main disease: a single high-volume center experience.
Sheiban C; Moretti C; La Spina C; Sillano D; Garrone P; Lombardi P; Sciuto F; Omedè P; Biondi-Zoccai G; Trevi GP
Minerva Cardioangiol; 2008 Aug; 56(4):381-6. PubMed ID: 18614981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
